Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures

por Vasudevan, Swetha, Adejumobi, Ibukun A., Alkhatib, Heba, Roy Chowdhury, Sangita, Stefansky, Shira, Rubinstein, Ariel M., Kravchenko-Balasha, Nataly
Publicado 2021

Overcoming resistance to BRAF(V600E) inhibition in melanoma by deciphering and targeting personalized protein network alterations

por Vasudevan, S., Flashner-Abramson, E., Alkhatib, Heba, Roy Chowdhury, Sangita, Adejumobi, I. A., Vilenski, D., Stefansky, S., Rubinstein, A. M., Kravchenko-Balasha, N.
Publicado 2021

Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance

por Alkhatib, Heba, Rubinstein, Ariel M., Vasudevan, Swetha, Flashner-Abramson, Efrat, Stefansky, Shira, Chowdhury, Sangita Roy, Oguche, Solomon, Peretz-Yablonsky, Tamar, Granit, Avital, Granot, Zvi, Ben-Porath, Ittai, Sheva, Kim, Feldman, Jon, Cohen, Noa E., Meirovitz, Amichay, Kravchenko-Balasha, Nataly
Publicado 2022